Literature DB >> 8839486

Interstitial stroma and carcinogenesis: ultrastructural observations in the rat bladder treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.

X H Zhang1, I Takenaka.   

Abstract

This study describes ultrastructural alterations of the interstitial stroma in the rat bladder epithelium during N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN)-induced bladder carcinogenesis using scanning (SEM) and transmission (TEM) electron microscopy with NaOH treatment. The results obtained with SEM demonstrated the occurrence and development of stroma protrusions which exhibited pipe-like structures in the rat bladder epithelium following administration of BBN. Number and size of blood vessel sections also gradually increased both in the stroma and within the layer of the proliferated epithelial cells as examined by light microscopy (LM) and TEM. In this study stroma alterations were not only observed in malignant lesions of rat bladder, but hyperplastic lesions were also accompanied by stroma alterations. It is suggested that: (1) the interstitial stroma of the rat bladder epithelium may exhibit pathological changes in structure and these changes may correlate with the progression of epithelial cell proliferation following administration of BBN and (2) one of the most important alterations in the stroma is the occurrence of neovascularization, which may induce structural modification of the stroma in the processes of bladder tumor growth and development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839486     DOI: 10.1007/bf00304082

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  18 in total

1.  Stromal changes in early invasive breast carcinoma. An immunohistochemical, histoenzymological and ultrastructural study.

Authors:  G Chomette; M Auriol; P Tranbaloc; J Blondon
Journal:  Pathol Res Pract       Date:  1990-02       Impact factor: 3.250

2.  Extracellular matrix in preneoplastic lesions and early cancer of the lung.

Authors:  A Fisseler-Eckhoff; M Prebeg; B Voss; K M Müller
Journal:  Pathol Res Pract       Date:  1990-02       Impact factor: 3.250

Review 3.  Tumor angiogenesis.

Authors:  J Folkman
Journal:  Adv Cancer Res       Date:  1974       Impact factor: 6.242

4.  Collagen fibrillar networks as skeletal frameworks: a demonstration by cell-maceration/scanning electron microscope method.

Authors:  O Ohtani; T Ushiki; T Taguchi; A Kikuta
Journal:  Arch Histol Cytol       Date:  1988-07

5.  Three-dimensional organization of the connective tissue fibers of the human pancreas: a scanning electron microscopic study of NaOH treated-tissues.

Authors:  O Ohtani
Journal:  Arch Histol Jpn       Date:  1987-12

6.  Basement membrane and tumor invasion: ultrastructural observations in the basement membrane of rat bladder with invasive transitional cell carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  X H Zhang; I Takenaka
Journal:  Urol Res       Date:  1994

Review 7.  Proliferation, basement membrane changes, metastasis and vascularization patterns in human breast cancer.

Authors:  D Verhoeven; E Van Marck
Journal:  Pathol Res Pract       Date:  1993-09       Impact factor: 3.250

8.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.

Authors:  E R Horak; R Leek; N Klenk; S LeJeune; K Smith; N Stuart; M Greenall; K Stepniewska; A L Harris
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

9.  Neovascularization in rats during urinary bladder carcinogenesis induced by N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide.

Authors:  S M Cohen; M Tatematsu; Y Shinohara; K Nakanishi; N Ito
Journal:  J Natl Cancer Inst       Date:  1980-07       Impact factor: 13.506

10.  Basement membrane and carcinogenesis: ultrastructural observations in the basement membrane of the bladder epithelium in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).

Authors:  X Zhang; N Matsuoka; M Sugimoto; I Takenaka
Journal:  Int J Urol       Date:  1994-06       Impact factor: 3.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.